Rivfloza
Payments companies reported to CMS as associated with Rivfloza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rivfloza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rivfloza
These are the largest totals companies reported as associated with Rivfloza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Prasad Devarajan | Cincinnati, OH | Pediatric Nephrology | $62,715.04 |
| Ephrem Olweny | Clifton, NJ | Urology | $47,442.46 |
| Anna Zisman | Chicago, IL | Internal Medicine | $17,597.86 |
| David Duong | Nashville, TN | Urology | $13,784.98 |
| Emily Blum | Atlanta, GA | Pediatric Urology | $9,742.16 |
| Deepa Malieckal | Brooklyn, NY | Internal Medicine | $6,119.39 |
| Tamara Hill | Baltimore, MD | Acute Care (Nurse Practitioner) | $5,477.39 |
| Rasheed Gbadegesin | Durham, NC | Pediatrics | $5,226.30 |
| Prince Anand | Danville, PA | Nephrology (Internal Medicine) | $4,317.50 |
| Fasika Tedla | New York, NY | Nephrology (Internal Medicine) | $2,747.50 |
Prescribed Rivfloza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.